Carmen E. Guerra, MD, MSCE, FACP
Internal Medicine
Sees patients age 18 and up
Penn Internal Medicine University City
Penn Medicine Provider

About me

  • Advisory Dean, Dr. Helen O. Dickens House, Perelman School of Medicine
  • Ruth C. and Raymond G. Perelman Professor of Medicine
  • Professor of Biostatistics and Epidemiology

NIH Office of Behavioral and Social Science Research

Robert Wood Johnson Amos Faculty Development Program

Education and training

  • Medical School: University of Rochester School of Medicine
  • Residency: Virginia Commonwealth University Nurse Anesthesia

What my patients think about me

Average Rating

143 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
great demeanor.
October 2025
doctor was efficient at inputting data at keyboard and still maintained communication. dr. guerra has a warm compassionate demeanor but at the same time doesn't pull punches. she educated me regarding the uspstf guidelines.
October 2025
very thorough, super sweet, takes her time to answer all my questions, keeps me on track with preventive care
October 2025
dr. guerra is the best. she is so smart and compassionate and an amazing clinician.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Guerra is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Perkins RB, Wolf AMD, Church TR, Elkin EB, Skates SJ, Etzioni RD, Guerra CE, Herzig A, Hoffman RM, Oeffinger KC, Raoof S, Shih YT, Walter LC, Zeigler-Johnson C, Manassaram‐Baptiste D, Smith RA Self-Collected Vaginal Specimens for Human Papillomavirus Testing and Guidance on Screening Exit: An Update to the American Cancer Society Cervical Cancer Screening Guidelines , CA Cancer J Clin, 76(1): 2026,e70041.


Islami F, Arias G, Lee D, Wiese D, Baeker Bispo J, Yabroff KR, Siegel RK, Bandi P, Nargis N, Patel AV, Thienprayoon PP, Kamal AH, Daniels EC, Annunziata CM, Sloan K, Lacasse LA, Winn RA, Brawley OW, Guerra CE, Dahut WL, , Jemal A. American Cancer Society’s Report on the Status of Cancer Disparities in the United States, 2025 , CA Cancer J Clin, 76(1): 2026,e70045


Kaparis S, Eshaghi K, Paruzzo L, Doshi J, Ruella M, Guerra CE CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy access , Blood Rev: 2025,01358


Gong IY, Soto MJ, Rafinejad-Farahani B, Unger JM, Conti RM, Guerra CE, Oza A, Rosenthal M, Rodin D. Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: a SEER-Medicare analysis. , Cancer, 131(24): 2025,e70204


Alan Mozes Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses , Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses: 2025


Gong IY, Rafinejad-Farahani B, Majeed H, Soto MJ, Oza A, Ehrlich T, Fernandez Lynch H, Guerra CE, Lofters A, Unger JM, Conti RM, Rosenthal M, Rodin D. Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023. Accepted for publication. , Leukemia and Lymphoma, 3: 2025,1-14


Alan Mozes Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses , Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses: 2025


Alan Mozes Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses , Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses: 2025


Alan Mozes Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses , Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses: 2025


Alan Mozes Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses , Medscape: 2025


View all publications